The pharmaceutical company boosted its profit outlook for the year, and raised its quarterly dividend as both third-quarter results and full-year guidance came in above expectations.
Source link
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Date:
More like thisRelated
Volkswagen Pauses Work on ID.Golf Model to Preserve Cash Flow
The German automaker said it will temporarily pause development...
NHL Power Rankings: New poll, all 32 teams as a horror movie
Greg WyshynskiOct 30, 2026, 08:00 AM ETCloseGreg Wyshynski is...